BDBM269504 (4-(4-fluorophenethyl)piperazin-1- yl)(2-phenylimidazo[1,2-a]pyridin- yl)methanone::US10058549, 9

SMILES Fc1ccc(CCN2CCN(CC2)C(=O)c2cccn3cc(nc23)-c2ccccc2)cc1

InChI Key InChIKey=MBHSPGRNAMMQGA-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 269504   

Target5-hydroxytryptamine receptor 2A(Human)
Arena Pharmaceuticals

US Patent
LigandPNGBDBM269504((4-(4-fluorophenethyl)piperazin-1- yl)(2-phenylimi...)
Affinity DataIC50: 46nMpH: 7.4 T: 2°CAssay Description:Radioligand binding assays for human 5-HT2A serotonin receptor were conducted using the 5-HT2 agonist [125I]DOI as radioligand. To define nonspecific...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2018
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Arena Pharmaceuticals

US Patent
LigandPNGBDBM269504((4-(4-fluorophenethyl)piperazin-1- yl)(2-phenylimi...)
Affinity DataIC50: 46nMpH: 7.4 T: 2°CAssay Description:Radioligand binding assays for human 5-HT2A serotonin receptor were conducted using the 5-HT2 agonist [125I]DOI as radioligand. To define nonspecific...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
Go to US Patent